- Since the acquisition of Alexion was completed, we were watching AstraZeneca from the sidelines. Holding but not taking any further action.
- Q4/FY 2021 earnings are marking a turning point for the company, for its future, for its dividend, and (consequently) for us. This has been nothing short of a superb quarter/year.
- AstraZeneca is not a Polish airline, but its new 'polish' looks great, and the stock seems set and ready to depart. High, up, and above.
- Since this is a pre-market trading alert, it doesn't contain all the details (obviously), but you will understand exactly what (we intend) to do.
For further details see:
AstraZeneca Is Looking As Polished As A New Aston Martin